Regeneron Pharmaceuticals (REGN) Gross Profit Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 411.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.16% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 4.34% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 51.16% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.34% |
| Dec 31, 2025 | 207.48% |
| Sep 30, 2025 | 8.38% |
| Jun 30, 2025 | 7.88% |
| Mar 31, 2025 | 171.40% |
| Dec 31, 2024 | -5.78% |
| Sep 30, 2024 | 2.22% |
| Jun 30, 2024 | -12.63% |
| Mar 31, 2024 | 7.96% |
| Dec 31, 2023 | 10.56% |
| Sep 30, 2023 | 13.36% |
| Jun 30, 2023 | 18.30% |
| Mar 31, 2023 | 18.53% |
| Dec 31, 2022 | -27.63% |
| Sep 30, 2022 | 19.09% |
| Jun 30, 2022 | 21.97% |
| Mar 31, 2022 | -28.54% |
| Dec 31, 2021 | 31.36% |
| Sep 30, 2021 | 26.92% |
| Jun 30, 2021 | 47.53% |
| Mar 31, 2021 | 16.96% |
| Dec 31, 2020 | 16.17% |
| Sep 30, 2020 | 14.45% |
| Jun 30, 2020 | 8.07% |
| Mar 31, 2020 | 11.63% |
| Dec 31, 2019 | 14.07% |
| Sep 30, 2019 | 11.14% |
| Jun 30, 2019 | 8.41% |
| Mar 31, 2019 | 4.26% |
| Dec 31, 2018 | 21.16% |
| Sep 30, 2018 | 13.96% |
| Jun 30, 2018 | 18.29% |
| Mar 31, 2018 | 21.02% |
| Dec 31, 2017 | 25.79% |
| Sep 30, 2017 | 27.75% |
| Jun 30, 2017 | 30.39% |
| Mar 31, 2017 | 28.10% |
| Dec 31, 2016 | 27.09% |
| Sep 30, 2016 | 27.91% |
| Jun 30, 2016 | 39.62% |
| Mar 31, 2016 | 39.68% |
| Dec 31, 2015 | 38.69% |
| Sep 30, 2015 | 37.96% |
| Jun 30, 2015 | 49.16% |
| Mar 31, 2015 | 55.61% |
| Dec 31, 2014 | 85.38% |
| Sep 30, 2014 | 89.08% |
| Jun 30, 2014 | 80.89% |
| Mar 31, 2014 | 74.90% |
| Dec 31, 2013 | 253.64% |
| Sep 30, 2013 | 399.50% |
| Jun 30, 2013 | 55.04% |
| Mar 31, 2013 | 606.16% |
| Dec 31, 2012 | 211.40% |
| Sep 30, 2012 | 51.59% |
| Jun 30, 2012 | 311.16% |